Evidence map›Paper›PMID 38853618›Full record

ReviewEndocrine reviews2024

Common and Uncommon Mouse Models of Growth Hormone Deficiency.

Edward O List, Reetobrata Basu, Darlene E Berryman, Silvana Duran-Ortiz, Gabriel Á Martos-Moreno, John J Kopchick

Abstract readReview
In one paragraph

Review in Endocrine reviews, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Synthesis ofMolecules (Basel, Switzerland) · 2026
    Article
  4. Sex Hormones and Metabolic Dysfunction-Associated Steatotic Liver Disease.International journal of molecular sciences · 2025
    Review
  5. Article
  6. Hypothalamic GHRH.Reviews in endocrine & metabolic disorders · 2025
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Edward O ListEdison Biotechnology Institute, Ohio University, Athens, OH 45701, USA.ORCID 0000-0002-8230-6331
Reetobrata BasuEdison Biotechnology Institute, Ohio University, Athens, OH 45701, USA.ORCID 0000-0001-8415-1356
Darlene E BerrymanEdison Biotechnology Institute, Ohio University, Athens, OH 45701, USA.ORCID 0000-0003-4240-9229
Silvana Duran-OrtizEdison Biotechnology Institute, Ohio University, Athens, OH 45701, USA.ORCID 0000-0001-8870-4077
Gabriel Á Martos-MorenoDepartment of Endocrinology & Pediatrics, Hospital Infantil Universitario Niño Jesús, IIS La Princesa & Universidad Autónoma de Madrid. CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, E28009, Spain.ORCID 0000-0001-5524-2646
John J KopchickEdison Biotechnology Institute, Ohio University, Athens, OH 45701, USA.ORCID 0000-0003-4561-2177

Funding

Modulating Growth Hormone Action as a Target for Improved Health and LongevityR01AG059779 · NIA · OHIO UNIVERSITY ATHENS · PI John Joseph Kopchick · 2018 to 2026
$4.7M
NIA NIH HHS R01 AG059779
6 · The paper itself

Abstract

Mouse models of growth hormone deficiency (GHD) have provided important tools for uncovering the various actions of GH. Nearly 100 years of research using these mouse lines has greatly enhanced our knowledge of the GH/IGF-1 axis. Some of the shared phenotypes of the 5 "common" mouse models of GHD include reduced body size, delayed sexual maturation, decreased fertility, reduced muscle mass, increased adiposity, and enhanced insulin sensitivity. Since these common mouse lines outlive their normal-sized littermates-and have protection from age-associated disease-they have become important fixtures in the aging field. On the other hand, the 12 "uncommon" mouse models of GHD described herein have tremendously divergent health outcomes ranging from beneficial aging phenotypes (similar to those described for the common models) to extremely detrimental features (such as improper development of the central nervous system, numerous sensory organ defects, and embryonic lethality). Moreover, advancements in next-generation sequencing technologies have led to the identification of an expanding array of genes that are recognized as causative agents to numerous rare syndromes with concomitant GHD. Accordingly, this review provides researchers with a comprehensive up-to-date collection of the common and uncommon mouse models of GHD that have been used to study various aspects of physiology and metabolism associated with multiple forms of GHD. For each mouse line presented, the closest comparable human syndromes are discussed providing important parallels to the clinic.

Indexed as

Disease Models, AnimalGrowth HormoneAnimalsDwarfism, PituitaryHumansInsulin-Like Growth Factor IMiceGrowth HormoneInsulin-Like Growth Factor Icombined pituitary hormone deficiencygrowth hormone deficiencyisolated growth hormone deficiencyknockout micemouse model

Identifiers

PMID38853618
PMCPMC12102728

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.